Here we showed that antagonizing M2R resulted in the inactivation of NF-κB p65, PI3K/Akt and MAPK ERK as well as the reversal of EMT and reduced migratory and invasive capacities in NSCLC. Here, NFKB1 is linked to non-small cell lung carcinoma.